Correll NL - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Evaluation of anti-activated protein C antibody development in patients with severe sepsis from four clinical studies with drotrecogin alpha (activated).

Yan SB, Brandt JT, Correll NL, Um SL, Bourdage JS. Yan SB, et al. Among authors: correll nl. J Thromb Haemost. 2009 Nov;7(11):1787-94. doi: 10.1111/j.1538-7836.2009.03601.x. J Thromb Haemost. 2009. PMID: 20015319 Free article. Clinical Trial.

ADDRESS (ADministration of DRotrecogin alfa [activated] in Early stage Severe Sepsis) long-term follow-up: one-year safety and efficacy evaluation.

Laterre PF, Abraham E, Janes JM, Trzaskoma BL, Correll NL, Booth FV. Laterre PF, et al. Among authors: correll nl. Crit Care Med. 2007 Jun;35(6):1457-63. doi: 10.1097/01.CCM.0000266588.95733.63. Crit Care Med. 2007. PMID: 17452935 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2 results

Search Page

Filters